Literature DB >> 14975783

Treatment of acrophobia in virtual reality: the role of immersion and presence.

Merel Krijn1, Paul M G Emmelkamp, Roeline Biemond, Claudius de Wilde de Ligny, Martijn J Schuemie, Charles A P G van der Mast.   

Abstract

In this study the effects of virtual reality exposure therapy (VRET) were investigated in patients with acrophobia. Feelings of presence in VRET were systematically varied by using either a head-mounted display (HMD) (low presence) or a computer automatic virtual environment (CAVE) (high presence). VRET in general was found to be more effective than no treatment. No differences were found in effectiveness between VRET using an HMD or CAVE. Results were maintained at 6 months follow-up. Results of VRET were comparable with those of exposure in vivo (Cyberpsychology and Behavior 4 (2001) 335). In treatment completers no relationship was found between presence and anxiety. Early drop-outs experienced less acrophobic complaints and psychopathology in general at pre-test. They also experienced less presence and anxiety in the virtual environment used in session one as compared to patients that completed VRET.

Entities:  

Mesh:

Year:  2004        PMID: 14975783     DOI: 10.1016/S0005-7967(03)00139-6

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  34 in total

1.  Does engagement with exposure yield better outcomes? Components of presence as a predictor of treatment response for virtual reality exposure therapy for social phobia.

Authors:  Matthew Price; Natasha Mehta; Erin B Tone; Page L Anderson
Journal:  J Anxiety Disord       Date:  2011-03-15

Review 2.  The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders.

Authors:  Jessica L Maples-Keller; Brian E Bunnell; Sae-Jin Kim; Barbara O Rothbaum
Journal:  Harv Rev Psychiatry       Date:  2017 May/Jun       Impact factor: 3.732

3.  Effectiveness of Self-guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Clinical Trial.

Authors:  Tara Donker; Ilja Cornelisz; Chris van Klaveren; Annemieke van Straten; Per Carlbring; Pim Cuijpers; Jean-Louis van Gelder
Journal:  JAMA Psychiatry       Date:  2019-07-01       Impact factor: 21.596

4.  Glucocorticoids enhance extinction-based psychotherapy.

Authors:  Dominique J-F de Quervain; Dorothée Bentz; Tanja Michael; Olivia C Bolt; Brenda K Wiederhold; Jürgen Margraf; Frank H Wilhelm
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

5.  Comparison of virtual reality based therapy with customized vestibular physical therapy for the treatment of vestibular disorders.

Authors:  Khalid A Alahmari; Patrick J Sparto; Gregory F Marchetti; Mark S Redfern; Joseph M Furman; Susan L Whitney
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2014-03       Impact factor: 3.802

6.  The role of presence in virtual reality exposure therapy.

Authors:  Matthew Price; Page Anderson
Journal:  J Anxiety Disord       Date:  2006-12-04

Review 7.  Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review.

Authors:  Cristina Botella; Javier Fernández-Álvarez; Verónica Guillén; Azucena García-Palacios; Rosa Baños
Journal:  Curr Psychiatry Rep       Date:  2017-07       Impact factor: 5.285

Review 8.  Promising technological innovations in cognitive training to treat eating-related behavior.

Authors:  Evan M Forman; Stephanie P Goldstein; Daniel Flack; Brittney C Evans; Stephanie M Manasse; Cara Dochat
Journal:  Appetite       Date:  2017-04-14       Impact factor: 3.868

9.  Using virtual reality to train inhibitory control and reduce binge eating: A proof-of-concept study.

Authors:  Stephanie M Manasse; Elizabeth W Lampe; Adrienne S Juarascio; Jichen Zhu; Evan M Forman
Journal:  Appetite       Date:  2020-10-10       Impact factor: 3.868

10.  Virtual environments using video capture for social phobia with psychosis.

Authors:  Lina Gega; Richard White; Timothy Clarke; Ruth Turner; David Fowler
Journal:  Cyberpsychol Behav Soc Netw       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.